| Autor: |
van Osdol WW; Simulations Plus, Incorporated, 42505 10th Street West, Lancaster, California, 93534, USA., Novakovic J; Simulations Plus, Incorporated, 42505 10th Street West, Lancaster, California, 93534, USA., Le Merdy M; Simulations Plus, Incorporated, 42505 10th Street West, Lancaster, California, 93534, USA., Tsakalozou E; Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Ghosh P; Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland, USA., Spires J; Simulations Plus, Incorporated, 42505 10th Street West, Lancaster, California, 93534, USA. jessica.spires@simulations-plus.com., Lukacova V; Simulations Plus, Incorporated, 42505 10th Street West, Lancaster, California, 93534, USA. |
Full text from SpringerLink